Barclays Maintains Overweight on Expro, Lowers Price Target to $20

Benzinga Newsdesk www.benzinga.com Negative 87.1%

Neg 87.1% Neu 0% Pos 0%

Barclays analyst David Anderson maintains Expro (NYSE:XPRO) with a Overweight and lowers the price target from $23 to $20.